(3) Considering the long‐term treatment responses of a proportion of psoriasis patients were unsatisfactory enough, it was meaningful to prolong the follow‐up duration to explore the ability of blood MALT1 for predicting long‐term treatment response in psoriasis patients. This evidence concerns the gene MALT1 and psoriasis.